Special Issue "Asymmetric Synthesis and Medicinal Chemistry"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 January 2010)
Prof. Dr. Oliver Reiser (Website)
Institut für Organische Chemie, Universität Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany
Fax: +49 (0)941 943 4121
Interests: asymmetric catalysis; stereoselective synthesis; natural product; synthesis; unnatural amino acids; foldamers
Dear Colleagues,Any new drug that¹s chiral is likely to be developed and marketed as a single enantiomer. You win more than you lose with single enantiomers.
This statement from an article in Chem. Eng. News emphasized in 2003 the importance of enantiopure pharmaceuticals. Asymmetric Synthesis and Medicinal Chemistry are areas closely related to each other, and very often fundamental contributions in the development of new asymmetric processes initially disclosed on small scale are transfered in a most impressive way into industrial applications, showing the relevance of those fields for academia and industry alike.
I would like to invite contributions to this special issue of Pharamceuticals "Asymmetric Synthesis and Medicinal Chemistry" as an opportunity to showcase the creativity of leading scientists to tackle the challenges in the development of chiral drugs.
Prof. Dr. Oliver Reiser